Core Points - The company has completed the registration of the third vesting period for the second reserved grant of the 2021 restricted stock incentive plan, with a total of 25,302 shares to be listed on November 24, 2025 [3][21][27] - The total number of shares after this vesting will increase from 315,196,071 to 315,221,373, and the conversion price of the "Aowei Convertible Bonds" will remain unchanged at 84.44 yuan per share [21][27][26] Summary by Sections Stock Listing and Vesting - The stock listing type is for equity incentive shares, with 25,302 shares being listed [2][3] - The decision-making process for the vesting of the restricted stock involved multiple board meetings and approvals, including independent opinions from directors [4][6][9] Vesting Details - A total of 41 individuals are eligible for this vesting, with the actual vesting of 25,302 shares [16][17] - The shares are sourced from the company's directed issuance of A-shares to the incentive targets [17] Financial Impact - The net profit attributable to shareholders for the first nine months of 2025 was approximately 390 million yuan, with a basic earnings per share of 1.24 yuan [19] - The newly vested shares represent about 0.0080% of the total shares before vesting, indicating minimal impact on the company's financial status [19][27] Registration and Verification - The verification of the vesting conditions was conducted by Lixin Zhonglian Accounting Firm, confirming the payment of 766,557.03 yuan for the shares [19] - The registration procedures for the shares were completed on November 14, 2025, with the relevant documentation provided by the Shanghai branch of the China Securities Depository and Clearing Corporation [19][21] Convertible Bond Price Adjustment - The conversion price of the "Aowei Convertible Bonds" will not be adjusted due to the small proportion of shares vested relative to the total share capital [21][27] - The calculation for the conversion price adjustment was detailed, confirming that the price remains at 84.44 yuan per share [26][27]

Group 1 - The company announced the completion of the third vesting period for the second reserved grant of the 2021 restricted stock incentive plan on November 14, 2025 [2] - The company's total share capital increased from 315,196,071 shares to 315,221,373 shares following the stock change [2] - The conversion price of the "Aoweizhuan Bond" remains unchanged after the capital change [2]

Market Overview - The A-share market experienced an overall decline on November 17, with the Shanghai Composite Index closing at 3972.03 points, down 0.46%, the Shenzhen Component Index at 13202 points, down 0.11%, and the ChiNext Index at 3105.2 points, down 0.2% [1] - The total trading volume for both markets was 19107.91 billion yuan, a decrease of 472.88 billion yuan compared to the previous trading day [1] Capital Flow - The net outflow of main funds from the Shanghai and Shenzhen markets reached approximately 170 billion yuan, with an opening net outflow of 58.8 billion yuan and a closing net inflow of 2.96 billion yuan, resulting in a total net outflow of 168.44 billion yuan for the day [2][3] - The CSI 300 index saw a net outflow of 83.5 billion yuan, while the ChiNext index experienced a net outflow of 75.05 billion yuan [4][5] Sector Performance - The computer industry achieved a net inflow of 80.23 billion yuan, with a growth of 1.92%, driven by stocks like Tuowei Information [6][7] - Other sectors with net inflows included media (31.27 billion yuan), communication (16.87 billion yuan), coal (10.69 billion yuan), and food and beverage (9.40 billion yuan) [7] - Conversely, the biopharmaceutical sector faced a significant net outflow of 156.04 billion yuan, declining by 1.57%, along with the electric equipment sector (90.44 billion yuan outflow) and banking (53.47 billion yuan outflow) [7] Institutional Activity - Notable institutional buying included Yahua Group with a net purchase of 41.69 million yuan and Binhai Energy with 19.24 million yuan [11] - Conversely, significant selling was observed in stocks like Shida Shenghua with a net outflow of 24694.51 million yuan and Zhongkuang Resources with 26231.12 million yuan [11] Analyst Recommendations - Recent analyst ratings include TuoBang Co. with a target price of 15.71 yuan, currently at 13.42 yuan, indicating a potential upside of 17.06% [12] - Other stocks with favorable ratings include Kede CNC with a target price of 86.95 yuan, currently at 60.79 yuan, suggesting a 43.03% upside [12]

证券代码：688516 证券简称：奥特维 公告编号：2025-117 转债代码：118042 转债简称：奥维转债 重要内容提示： 无锡奥特维科技股份有限公司 关于本次限制性股票归属登记完成后 不调整"奥维转债"转股价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依 法承担法律责任。 ●无锡奥特维科技股份有限公司（以下简称"公司"）已于2025年11 月14日完成了2021年限制性股票激励计划第二次预留授予部分第三 个 归 属 期 的 股 份 登 记 手 续 , 公 司 股 本 由 315,196,071 股 变 更 为 315,221,373股。经计算，本次股本变更后"奥维转债"转股价格不 变。 一、 转债价格调整依据 根据中国证券监督管理委员会关于可转换公司债券发行的有关 规定及公司于 2023 年 8 月 8 日在上海证券交易所网站（www.sse.com） 披露的《无锡奥特维科技股份有限公司向不特定对象发行可转换公司 ●调整前转股价格：84.44 元/股 ●调整后转股价格：84.44 元/股 债券募集说明书》（以下简称"募集 ...

证券代码：688516 证券简称：奥特维 公告编号：2025-116 转债代码：118042 转债简称：奥维转债 无锡奥特维科技股份有限公司 关于 2021 年限制性股票激励计划第二次预留授予部分 第三个归属期归属结果暨股份上市公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ●本次股票上市类型为股权激励股份；股票认购方式为网下，上市股数为 25,302股（第二次预留授予部分第三个归属期）。 本次股票上市流通总数为25,302股。 ● 本次股票上市流通日期为2025 年 11 月 24 日。 根据中国证券监督管理委员会、上海证券交易所、中国证券登记结算有限责 任公司上海分公司有关业务规则的规定，无锡奥特维科技股份有限公司（以下简 称"公司"）于近日收到中国证券登记结算有限责任公司上海分公司出具的《证 券变更登记证明》，公司已完成 2021 年限制性股票激励计划（以下简称"本激励 计划"）第二次预留授予部分第三个归属期的股份登记工作。现将有关情况公告 如下： 一、本次限制性股票归属的决策程序及相关信息披露 ...

中国经济网北京11月17日讯 奥特维(688516.SH)日前发布了2025年第三季度报告。 2025年前三季度，公司营业收入46.72亿元，同比减少32.67%；归属于上市公司股东的净利润3.90 亿元，同比减少67.68%；归属于上市公司股东的扣除非经常性损益的净利润3.43亿元，同比减少 71.21%；经营活动产生的现金流量净额5.49亿元，同比增长48.83%。 | | | | | 早区: 元 中 : 人民日 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 本报告期比 上年同期增 | 年初至报告期末 | 年初至报告期 末比上年同期 | | | | 减变动幅度 | | 增减变动幅度 | | | | (%) | | (%) | | 营业收入 | 1,292,484,360.35 | -48.65 | 4,671,861,477.73 | -32.67 | | 利润总额 | 50,025,444.55 | -90.04 | 408,584,888.69 | -71.27 | | 归属于上市公司股东的 | 82,426,762.46 | -81.54 | 390 ...

Investment Rating - The report maintains a "Buy" rating for the company [7][6]. Core Insights - In the first three quarters of 2025, the company reported a revenue of 4.672 billion yuan, a year-on-year decrease of 32.67%. The net profit attributable to shareholders was 390 million yuan, down 67.68% year-on-year. For Q3 2025, revenue was 1.292 billion yuan, a decline of 48.65% year-on-year and 29.96% quarter-on-quarter. The net profit for Q3 was 82 million yuan, down 81.54% year-on-year and 50.46% quarter-on-quarter [2][4]. Revenue and Profit Analysis - Q3 revenue decline was primarily due to slower acceptance rates, although shipments remained normal. The report anticipates an increase in the proportion of revenue from string welding machines and modifications, while the share from single crystal furnaces and screen printing is expected to decrease. The gross margin for Q3 was 36.6%, an increase of 4.6% year-on-year and 8.3% quarter-on-quarter, attributed to a lower proportion of low-margin products [12][12]. - The expense ratio for Q3 was 25.0%, an increase of 11.1 percentage points quarter-on-quarter, influenced by revenue decline and increased R&D and management expenses. Asset impairment losses and credit impairment losses for Q3 were -73 million yuan and -45 million yuan, respectively, impacting profit release [12][12]. Future Outlook - As of the end of Q3, the company had an order backlog of 9.940 billion yuan (including tax), with semiconductor orders reaching a new high and continuing to grow. In the photovoltaic sector, new capacity demand has decreased due to industry cycles, while demand for technological upgrades has increased. The company has developed compatible multi-slice edge passivation equipment, which is currently undergoing small-batch trial production at client sites [12][12]. - In the lithium battery sector, the company has laid out equipment for sulfide electrolytes, stacking equipment, and assembly equipment, signing a strategic cooperation agreement with Yili Technology, and has secured orders exceeding 10 million yuan. The company has also developed several products for negative electrode material equipment, successfully obtaining an order for silicon oxide sintering furnace equipment from a lithium battery materials company in Vietnam [12][12]. - In the semiconductor sector, packaging equipment has received orders from clients such as Optoelectronics, Global Broadcasting, and others. The prototypes for flip chip bonding machines and die attach machines have shown good results in client validation, and the company is continuously optimizing based on client needs [12][12].

Group 1 - The article highlights the top 20 stocks in the S&P China A-Share Dividend Opportunity Index, showcasing significant daily and year-to-date gains along with their dividend yields [1] - The stock with the highest daily gain is LuRi Co., Ltd. (002083.SZ) with a 9.99% increase and a year-to-date gain of 143.49% [1] - Tibet Pharmaceutical (600211.SH) and Youfa Group (601686.SH) also show strong performance with year-to-date gains of 35.24% and 29.54% respectively, along with dividend yields of 3.99% and 4.38% [1] Group 2 - The index includes companies with varying dividend yields, with JiaFeiYa (002572.SZ) having the highest yield at 7.35%, despite a year-to-date decline of 14.75% [1] - Other notable companies include China Bank (601988.SH) with a year-to-date gain of 10.34% and a dividend yield of 3.86%, and Gujia Home (603816.SH) with a 17.77% gain and a yield of 4.52% [1] - The overall performance of the index reflects a mix of high-growth stocks and those offering attractive dividends, indicating diverse investment opportunities [1]

11月14日，奥特维盘中上涨2.13%，截至09:48，报45.64元/股，成交7870.81万元，换手率0.56%，总市 值143.86亿元。 资金流向方面，主力资金净流入76.56万元，特大单买入147.23万元，占比1.87%，卖出256.19万元，占 比3.25%；大单买入1497.63万元，占比19.03%，卖出1312.11万元，占比16.67%。 奥特维今年以来股价涨10.75%，近5个交易日跌1.34%，近20日涨8.67%，近60日涨25.90%。 资料显示，无锡奥特维科技股份有限公司位于江苏省无锡新吴区新华路3号，成立日期2010年2月1日， 上市日期2020年5月21日，公司主营业务涉及高端智能装备的研发、设计、生产和销售。主营业务收入 构成为：光伏设备78.86%，改造及其他主营业务13.61%，锂电设备5.20%，半导体2.13%，其他(补 充)0.19%。 奥特维所属申万行业为：电力设备-光伏设备-光伏加工设备。所属概念板块包括：半导体设备、机器视 觉、中盘、半导体、固态电池等。 分红方面，奥特维A股上市后累计派现18.84亿元。近三年，累计派现16.27亿元。 机构持仓方面，截止 ...

Core Insights - The article provides an overview of the latest fund net asset values, highlighting the top-performing and bottom-performing funds in the market [1] Fund Performance Summary Top 10 Funds by Net Value Growth - The top 10 funds with the highest net value growth include: 1. E Fund S&P Biotechnology RMB C: 1.5967, growth of 3.31% 2. E Fund S&P Biotechnology RMB A: 1.6184, growth of 3.31% 3. E Fund S&P Biotechnology USD A: 0.2284, growth of 3.30% 4. E Fund S&P Biotechnology USD C: 0.2253, growth of 3.30% 5. Vanguard Growth A: 1.0911, growth of 2.95% 6. Shenwan Hongyuan Medical A: 0.4952, growth of 2.95% 7. Vanguard Growth C: 1.1104, growth of 2.95% 8. Shenwan Hongyuan Medical C: 0.4867, growth of 2.94% 9. Fuguo Medical Innovation A: 1.8086, growth of 2.86% 10. Fuguo Medical Innovation C: 1.7890, growth of 2.86% [2] Bottom 10 Funds by Net Value Decline - The bottom 10 funds with the largest net value decline include: 1. Dongcai Value Start C: 0.8164, decline of 5.32% 2. Dongcai Value Start A: 0.8302, decline of 5.31% 3. HSBC Jintrust Low Carbon Pioneer A: 3.0533, decline of 4.87% 4. HSBC Jintrust Low Carbon Pioneer C: 2.9915, decline of 4.87% 5. HSBC Jintrust Research Selected Mixed: 1.0754, decline of 4.86% 6. HSBC Jintrust Core Growth A: 1.0195, decline of 4.70% 7. HSBC Jintrust Core Growth C: 0.9970, decline of 4.69% 8. Ping An Research Selected Mixed C: 0.8939, decline of 4.65% 9. Ping An Research Selected Mixed A: 0.9228, decline of 4.64% 10. HSBC Jintrust Intelligent Manufacturing Pioneer C: 2.8535, decline of 4.63% [3] Market Overview - The Shanghai Composite Index opened lower but rebounded, closing slightly down, with a trading volume of 1.96 trillion yuan and a stock performance ratio of 1758 gainers to 3563 losers [5] - Leading sectors include insurance, oil, banking, textiles, and household appliances, while the concept of immunotherapy saw a rise of over 2% [6] - Declining sectors include mineral products and electrical equipment, both dropping over 2% [7] Fund Holdings Analysis E Fund S&P Biotechnology Holdings - The fund's top holdings include: 1. CRISPR Therapeutics AG: 2.14% 2. Exelixis Inc: 1.89% 3. AbbVie Inc: 1.89% 4. Madrigal Pharmaceuticals Inc: 1.84% 5. Moderna Inc: 1.83% - The fund has a concentration of 18.47% in its top ten holdings, focusing on the pharmaceutical sector, and has outperformed the market [8] Dongcai Value Start Holdings - The fund's top holdings include: 1. Longi Green Energy: -7.35% 2. Foster: -6.08% 3. Zhongyou Technology: -2.11% 4. Yinke Co.: -0.74% 5. Xinyi Solar: -4.27% - The fund has a concentration of 47.27% in its top ten holdings, focusing on the renewable energy sector, and has underperformed the market [8]